Skip to main content
Skip to navigation

Extras
Newsletters
Jobs
Reading room
Puzzles

Publishing
Education
Membership

Celebrating twenty years

Mast navigation

Sign In
Register
Subscribe

Search our site

Search our site

Home
News
Research
Industry
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Members

Home
News
Research
Industry
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Members
More navigation items

Merck & Co to buy Afferent for neurology drugs

By Phillip Broadwith2016-06-13T00:00:00

Deal worth up to $1.25bn includes drug candidate for chronic coughs

Subscribe
Advertise
Topics
Issues
Contributors
RSS

Help
Contact
Privacy
Cookies
Terms of use
Accessibility
Permissions

Our mission
News and events
Campaigns
Awards and funding
Global challenges
Support our work

© Royal Society of Chemistry Registered charity number: 207890

This website collects cookies to deliver a better user experience. See how this site uses cookies.
This website collects cookies to deliver a better user experience. Do not sell my personal data.
Este site coleta cookies para oferecer uma melhor experiência ao usuário. Veja como este site usa cookies.

Site powered by Webvision Cloud